PLX logo

Protalix BioTherapeutics, Inc.

PLX
Healthcare|Biotechnology|US
$2.54
+0.03 (+0.99%)
Tangible Book / Share
$0.89
Graham Number
$2.18
Cash / Share
$0.51

Ownership Breakdown

96.1%
Float
80.6M
Shares Outstanding
77.4M
Float Shares

Major Holders (5)

Combined: 23.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
HOLD Alapkezelo Zrt.Other5.20%4,157,791Oct 15, 202613D/G
BlackRock, Inc.Holding company5.02%4,046,650Jul 29, 202613D/G
Kaufman Michael AIndividual4.50%3,616,289Mar 30, 202613D/G
Mak Capital One LLCInvestment adviser4.50%3,616,289Mar 30, 202613D/G
MAK Capital Fund LPPartnership4.50%3,616,289Mar 30, 202613D/G

Insider Trades (100)

Last 4 quarters: 1,779,000 acquired · 168 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Schwartz AharondirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Schwartz AharondirectorSep 3, 2026AWARD8,500——Form 4
Naos YaronSr. VP & COOSep 3, 2026AWARD112,000$2.59$290.1KForm 4
Naos YaronSr. VP & COOSep 3, 2026AWARD56,000——Form 4
Elze ChristiandirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Melincoff Gwen AdirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Melincoff Gwen AdirectorSep 3, 2026AWARD8,500——Form 4
Elze ChristiandirectorSep 3, 2026AWARD8,500——Form 4
Boudes Pol FdirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Boudes Pol FdirectorSep 3, 2026AWARD8,500——Form 4
Bashan Drordirector, officer: PRESIDENT AND CEOSep 3, 2026AWARD320,000$2.59$828.8KForm 4
Bashan Drordirector, officer: PRESIDENT AND CEOSep 3, 2026AWARD160,000——Form 4
Bar-Shalev AmosdirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Bar-Shalev AmosdirectorSep 3, 2026AWARD8,500——Form 4
Ben Zvi ShmueldirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Ben Zvi ShmueldirectorSep 3, 2026AWARD8,500——Form 4
Forster EliotdirectorSep 3, 2026AWARD17,000$2.59$44.0KForm 4
Forster EliotdirectorSep 3, 2026AWARD8,500——Form 4
Mamlok GiladSr. VP and CFOAug 24, 2025OTHER0——Form 4
Bashan Drordirector, officer: PRESIDENT AND CEODec 19, 2025BUY56,000$1.81$101.4KForm 4
Bar-Shalev AmosdirectorNov 18, 2025SELL168$1.87$314.16Form 4
Melincoff Gwen AdirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Forster EliotdirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Melincoff Gwen AdirectorSep 3, 2025AWARD7,500——Form 4
Forster EliotdirectorSep 3, 2025AWARD7,500——Form 4
Boudes Pol FdirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Boudes Pol FdirectorSep 3, 2025AWARD7,500——Form 4
Elze ChristiandirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Schwartz AharondirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Elze ChristiandirectorSep 3, 2025AWARD7,500——Form 4
Schwartz AharondirectorSep 3, 2025AWARD7,500——Form 4
Ben Zvi ShmueldirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Ben Zvi ShmueldirectorSep 3, 2025AWARD7,500——Form 4
Bar-Shalev AmosdirectorSep 3, 2025AWARD15,000$1.64$24.6KForm 4
Bar-Shalev AmosdirectorSep 3, 2025AWARD7,500——Form 4
Naos YaronSr. VP, OperationsSep 3, 2025AWARD25,000——Form 4
Naos YaronSr. VP, OperationsSep 3, 2025AWARD50,000$1.64$82.0KForm 4
Bashan Drordirector, officer: PRESIDENT AND CEOSep 3, 2025AWARD195,000——Form 4
Bashan Drordirector, officer: PRESIDENT AND CEOSep 3, 2025AWARD340,000$1.64$557.6KForm 4
Mamlok GiladSr. VP and CFOAug 24, 2025OTHER597,990$1.45$867.1KForm 4
Schwartz AharondirectorJun 10, 2025BUY129,000$1.60$205.9KForm 4
Elze ChristianJun 26, 2025OTHER0——Form 4
Rubin EyalSr. VP and CFOSep 23, 2024AWARD90,909——Form 4
Rubin EyalSr. VP and CFOSep 23, 2024AWARD99,010——Form 4
Naos YaronSr. VP, OperationsSep 23, 2024AWARD100,000$1.10$110.0KForm 4
Bashan Drordirector, officer: PRESIDENT AND CEOApr 1, 2024AWARD263,960——Form 4
Bashan Drordirector, officer: PRESIDENT AND CEOOct 19, 2023BUY16,129$1.41$22.7KForm 4
Bashan Drordirector, officer: PRESIDENT AND CEOOct 19, 2023BUY48,387$1.40$67.7KForm 4
Boudes Pol FdirectorSep 29, 2023AWARD61,676$1.66$102.4KForm 4
Melincoff Gwen AdirectorSep 29, 2023AWARD61,676$1.66$102.4KForm 4
Bar-Shalev AmosdirectorSep 29, 2023AWARD61,676$1.66$102.4KForm 4
Ben Zvi ShmueldirectorSep 29, 2023AWARD61,676$1.66$102.4KForm 4
Schwartz AharondirectorSep 29, 2023AWARD61,676$1.66$102.4KForm 4
Forster EliotdirectorSep 14, 2023AWARD85,715$1.75$150.0KForm 4
Forster Eliotdirector: Sep 14, 2023OTHER0——Form 4
Bashan Drordirector, officer: President and CEOAug 15, 2023AWARD800,000——Form 4
Rubin EyalSr. VP and CFOAug 15, 2023AWARD201,903——Form 4
Hayon YaelVP, Research & DevelopmentAug 15, 2023AWARD35,115$1.99$69.9KForm 4
Hayon YaelVP, Research & DevelopmentAug 15, 2023AWARD35,115——Form 4
Naos YaronSr. VP, OperationsAug 15, 2023AWARD187,344——Form 4
Schwartz AharondirectorJan 3, 2023BUY110,000$1.42$155.8KForm 4
Ben Zvi Shmueldirector: Sep 7, 2022AWARD10,000——Form 4
Naos YaronSr. VP, OperationsSep 7, 2022AWARD340,000——Form 4
Hayon YaelVP, Research & DevelopmentSep 7, 2022AWARD250,000——Form 4
Rubin EyalSr. VP and CFOSep 7, 2022AWARD350,000$1.03$360.5KForm 4
Rubin EyalSr. VP and CFOSep 7, 2022AWARD350,000——Form 4
Bashan DrorPresident and CEOSep 7, 2022AWARD750,000——Form 4
Schwartz Aharondirector: Sep 7, 2022AWARD50,000——Form 4
Bronfeld ZeevdirectorSep 7, 2022AWARD100,000$1.03$103.0KForm 4
Bronfeld Zeevdirector: Sep 7, 2022AWARD100,000——Form 4
Bar-Shalev Amosdirector: Sep 7, 2022AWARD50,000——Form 4
Melincoff Gwen AdirectorSep 7, 2022AWARD50,000$1.03$51.5KForm 4
Melincoff Gwen Adirector: Sep 7, 2022AWARD50,000——Form 4
Boudes Pol Fdirector: Sep 7, 2022AWARD50,000——Form 4
Ben Zvi Shmueldirector: Jun 30, 2022AWARD40,000——Form 4
Ben Zvi Shmueldirector: Jun 30, 2022OTHER0——Form 4
Bashan DrorPresident and CEOApr 11, 2022BUY68,000$1.50$102.0KForm 4
Rubin EyalSr. VP and CFOFeb 25, 2022AWARD121,951——Form 4
Bashan Drordirector, officer: President and CEOFeb 25, 2022AWARD637,531——Form 4
Dexcel Pharma Technologies Ltd.10 percent ownerJun 2, 2021SELL61,211$2.56$156.6KForm 4
Dexcel Pharma Technologies Ltd.10 percent ownerJun 3, 2021SELL857,506$2.25$1.9MForm 4
Dexcel Pharma Technologies Ltd.10 percent ownerFeb 12, 2021DISPOSED0——Form 4
Dexcel Pharma Technologies Ltd.10 percent ownerMar 11, 2020DISPOSED2,816,901$2.36$6.6MForm 4
Rubin EyalSr. VP and CFOAug 11, 2020AWARD246,146——Form 4
Bashan Drordirector, officer: President and CEOAug 11, 2020AWARD447,927——Form 4
Naos YaronSr. VP, OperationsAug 11, 2020AWARD122,656$3.59$440.3KForm 4
Hayon YaelVP, Research & DevelopmentJul 5, 2020AWARD129,771$3.73$484.0KForm 4
Hayon YaelofficerJul 5, 2020OTHER0——Form 4
Almon Einat BrillSVP, Chief Development OfficerJun 7, 2020AWARD196,995$3.59$707.2KForm 4
Schwartz AharondirectorApr 7, 2020BUY64,000$2.43$155.3KForm 4
Bronfeld ZeevdirectorFeb 3, 2020AWARD240,000$3.70$888.0KForm 4
Granot DaviddirectorJan 20, 2020AWARD40,000$3.55$142.0KForm 4
Bar-Shalev AmosdirectorJan 20, 2020AWARD40,000$3.55$142.0KForm 4
Schwartz AharondirectorJan 20, 2020AWARD40,000$3.55$142.0KForm 4
Boudes Pol FdirectorJan 20, 2020AWARD40,000$3.55$142.0KForm 4
Melincoff Gwen AdirectorJan 20, 2020AWARD40,000$3.55$142.0KForm 4
Melincoff Gwen Adirector: Jan 1, 2020OTHER0——Form 4
Boudes Pol FdirectorJan 1, 2020DISPOSED0——Form 4
Rubin EyalSr. VP & CFOSep 22, 2019AWARD800,000$0.20$160.0KForm 4
Rubin EyalofficerSep 22, 2019OTHER0——Form 4